Håkan Schulz

Title: Håkan Schulz: Innovator in Pharmaceutical Chemistry

Introduction

Håkan Schulz is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel therapeutic compounds. His work has led to the filing of a patent that showcases his innovative approach to drug formulation.

Latest Patents

Håkan Schulz holds a patent for "Pharmaceutically acceptable salts of methyl (3-{ [[3-(6-amino-2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl) propyl] (3-morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy." This invention concerns hydrochloric acid, hydrobromic acid, and maleic acid salts of the compound, along with compositions comprising them and their therapeutic applications. He has 1 patent to his name.

Career Highlights

Throughout his career, Håkan has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with AstraZeneca AB and Dainippon Sumitomo Pharma Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Håkan Schulz has collaborated with various professionals in his field, including his coworker Thomas McInally. These collaborations have likely enhanced his research and development efforts, leading to impactful innovations in pharmaceutical sciences.

Conclusion

Håkan Schulz is a distinguished inventor whose work in pharmaceutical chemistry has resulted in valuable patents and collaborations. His contributions continue to influence the development of therapeutic compounds, showcasing the importance of innovation in healthcare.